Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q28244389)
scientific article (publication date: September 2007)
Language:
(P31) (Q13442814)
(P50) (Q54086625)
(Q45945017)
(Q54086626)
(Q80249619)
(Q15077133)
(P304) 1102-1107
(P407) (Q1860)
(P433) 9
(P478) 13
(P577) Sunday, September 2, 2007
(P921) (Q41112)
(Q42824440)
(P1433) (Q1633234)
(P1476) "Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial" (language: en)
(P2093) Sandeep T Patil
Lu Zhang
Ferenc Martenyi
Stephen L Lowe
Kimberley A Jackson
Alla S Avedisova
Issak Y Gurovich
Nikolai G Neznanov
Alexander M Reznik
Vladimir A Tochilov
Bryan G Johnson
James A Monn
Darryle D Schoepp
(P2507) (Q60637647)
(P2860) (Q40821108)
(Q41108878)
(Q34598119)
(Q28280906)
(Q36185191)
(Q45056381)
(Q22251177)
(Q45122746)
(Q28240880)
(Q34200339)
(Q44220837)
(Q28138722)
(Q48733614)
(Q28201788)
(Q28140916)
(Q44259217)
(Q40710508)
(Q48139280)
(Q44186049)
(Q35063070)
(Q42546433)
(Q44182691)
other details
description scientific article (publication date: September 2007)

External Links